Navigation Links
DOR BioPharma Announces Publication of orBec(R) Clinical Pulmonary Data in Bone Marrow Transplantation
Date:6/29/2009

ryptogenic organizing pneumonia, as compared to none of the orBec(R)-treated patients (p = 0.04).

The investigators, led by Dr. Jason Chien, reviewed data from two previous randomized, double-blind, placebo-controlled Phase 2 and 3 clinical trials evaluating orBec(R), for the treatment of acute GI GVHD. Data from 120 patients (sixty patients treated with orBec(R), sixty placebo) were available for this retrospective analysis. Patients were enrolled in these studies at the Fred Hutchinson Cancer Research Center, where pulmonary function testing is done prospectively and all patients with pulmonary complications are evaluated with a standard protocol. The investigators also evaluated adverse event reports of infectious and non-infectious inflammation of the lung.

These observations by Dr. Chien and colleagues on the preservation of pulmonary function among patients receiving orBec(R) is consistent with findings from the Phase 3 randomized trial reported by Hockenbery et al. (A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease. Blood 109: 4557 - 4563, 2007).

"While these trials were not designed to look at pulmonary endpoints, these observations suggest that a metabolite of oral BDP may be having a beneficial anti-inflammatory effect in the lungs of hematopoietic cell transplant recipients," stated Jason W. Chien, MD, MS, Assistant Member, Clinical Research Division of the Fred Hutchinson Cancer Research Center. "There was convincing evidence of preservation of lung function and an absence of non-infectious pulmonary disease in those who had received oral BDP. The explanation for this benefit appears to be related to the delivery of a small amount of the potent metabolite, 17-beclomethasone monopropionate, from the intestinal mucosa to the pulmonary artery via the p
'/>"/>

SOURCE DOR BioPharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
2. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
3. PDL BioPharma Announces Internal CEO Investigation Found No Credible Evidence of Improper Personal Conduct or Breach of Fiduciary Duty
4. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
5. PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development
6. XTL Biopharmaceuticals Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C at an Upcoming International Scientific Conference
7. XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain
8. Nabi Biopharmaceuticals Announces Sale of Nabi Biologics to Biotest AG
9. Keryx Biopharmaceuticals to Present at Bank of America Investment Conference
10. Morria Biopharmaceuticals Plc Announces Appointment of Dr. Rosemary Mazanet as Interim Chief Executive Officer
11. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... CA and ANNAPOLIS JUNCTION, MD (PRWEB) September 23, 2014 ... and research leader in personalized medicine, presented industry leading ... opioid misuse this past weekend at the American ... Meeting. The meeting took place in Phoenix, Arizona at ... proprietary study on the linkage between gender and genetic ...
(Date:9/23/2014)... , Sept. 23, 2014  Age Defying Dermatology ® ... , has become one of the first clinics in ... "picoseconds" aesthetic laser for tattoo removal. The treatment safely ... results. "For years, tattoo removal has been a lengthy, ... Noodleman. "This is an opportunity to erase tattoo pigment ...
(Date:9/23/2014)... Texas (PRWEB) September 23, 2014 ... on the Global and China Isopropanol (IPA) industry. ... industry, including definitions, applications and industry chain structure. ... are provided with a focus on history, developments, ... comparison between the international and Chinese situation is ...
(Date:9/23/2014)... , September 23, 2014 ... Closed System Transfer     Devices  (CSTD) ... partnership with Taiwanese distributor MedFront Medical Technology Corporation.  Equashield,s leading ... Taiwan , China ... the company continues to expand globally, and throughout ...
Breaking Biology Technology:Proove Biosciences Will Be Exhibiting I.M.P.L.O.R.E Study at the American Academy of Pain Management 25th Annual Meeting 2Proove Biosciences Will Be Exhibiting I.M.P.L.O.R.E Study at the American Academy of Pain Management 25th Annual Meeting 3Age Defy Now Offers World's Most Advanced Technology for Tattoo Removal 2(IPA) Isopropanol Industry International & China Development Trend Analysis Now Available at DeepResearchReports.com 2(IPA) Isopropanol Industry International & China Development Trend Analysis Now Available at DeepResearchReports.com 3Equashield Enters Taiwan Following Expansion to Australia, Japan, China 2
... Company,s Move Driven by Commitment of Governor and ... with Leading Stem Cell Researcher, EWING, N.J., May 1 ... Coast operations in Ewing, N.J., The move, which was ... New Jersey Economic Development Authority,puts StemCyte,s executives in close proximity ...
... Representatives Unveil State-of-the-Art Facility ... ... Officials from Novavax,Inc. (Nasdaq: NVAX ), the State of ... state-of-the-art vaccine production,facility at the company,s headquarters in Rockville, Maryland. ...
... Halozyme Therapeutics, Inc.,(Nasdaq: HALO ), a biopharmaceutical ... today announced that it will,release financial results for ... close on Thursday, May 8, 2008., Jonathan ... Frost,PhD, Vice President and Chief Scientific Officer, Robert ...
Cached Biology Technology:StemCyte Locates East Coast Operations in New Jersey 2Novavax Opens Its First U.S. Vaccine Plant 2Novavax Opens Its First U.S. Vaccine Plant 3Novavax Opens Its First U.S. Vaccine Plant 4Halozyme Therapeutics to Hold Pipeline Update Conference Call on May 9 2
(Date:9/23/2014)... to do the washing up, negotiating rights to the TV ... returning to university for the new academic year are about ... a tricky business. , And now research from academics at ... allow people to monitor their energy usage in the home ... study by a team of technology experts and psychologists found ...
(Date:9/23/2014)... be as good for your mental as your physical ... the University of Warwick,s Medical School using data from ... BMJ Open focused on mental wellbeing and found ... with an individual,s fruit and vegetable consumption. , 33.5% ... more portions of fruit and vegetables a day, compared ...
(Date:9/23/2014)... CORAL SPRINGS, Florida , September 23, 2014 ... listings for innovative companies in tech sector position for significant ... generation products & services.  Companies in focus today are: NXT-ID, ... (NYSE: BABA ), Mobileye N.V. (NYSE: ... ReWalk Robotics Ltd. (NASDAQ: RWLK) NXT-ID, Inc. (NASDAQ: ...
Breaking Biology News(10 mins):Smart meters could cause conflict for housemates, study shows 2Smart meters could cause conflict for housemates, study shows 3Eating five a day may keep the blues away 2Latest Blockbuster IPOs and Up Listings for Global Tech Stocks Attracting Major Attention as Traders Focus on Key Economic Data Due this Week 2Latest Blockbuster IPOs and Up Listings for Global Tech Stocks Attracting Major Attention as Traders Focus on Key Economic Data Due this Week 3Latest Blockbuster IPOs and Up Listings for Global Tech Stocks Attracting Major Attention as Traders Focus on Key Economic Data Due this Week 4Latest Blockbuster IPOs and Up Listings for Global Tech Stocks Attracting Major Attention as Traders Focus on Key Economic Data Due this Week 5Latest Blockbuster IPOs and Up Listings for Global Tech Stocks Attracting Major Attention as Traders Focus on Key Economic Data Due this Week 6Latest Blockbuster IPOs and Up Listings for Global Tech Stocks Attracting Major Attention as Traders Focus on Key Economic Data Due this Week 7
... WASHINGTON -- The National Academy of Sciences (NAS) will ... scientific achievements in the areas of biology, chemistry, geology, ... JOHN ALROY, associate researcher at the National Center ... California, Santa Barbara, is the recipient of the NAS ...
... Householders in the UK should be looking beyond their ... to scientists at the University of Leeds. To ... to create a network of interlinking habitats where birds, ... in isolation, they link together to form interconnected habitat ...
... has documented that Yasun National Park, in the core of ... of plant and animal groups, from amphibians to trees to ... development projects represent the greatest threat to Yasun and its ... most diverse area in South America, and possibly the world," ...
Cached Biology News:NAS honors 17 for major contributions to science 2NAS honors 17 for major contributions to science 3NAS honors 17 for major contributions to science 4NAS honors 17 for major contributions to science 5Gardeners must unite to save Britain's wildlife 2Scientists identify Ecuador's Yasuni National Park as one of most biodiverse places on earth 2